(Reuters) – Ironwood Pharmaceuticals Inc IRWD.O said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial. Shares of the drugmaker fell 8% to $8.80, after the company also said it would […]
Sunday, Jul 3, 2022
Breaking News